Neurava

Neurava

Private
Indianapolis, IndianaHealthcare & Life Scienceshttps://www.neurava.com

Last Round

Seed

Apr 3, 2024

Total Funding Raised

$2.96M

Momentum Score

25 /100

Company Overview

Neurava is a healthcare technology company that develops a non-invasive wearable diagnostic device to empower patients with uncontrolled epilepsy by monitoring key biological signals and providing timely alerts for caregivers.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Health IoT, Sensors

Business Model

B2B2C

Customer Profile

Hardware + Subscription, Subscription SaaS, Hardware Sales

AI Layer

Application

Keywords

SUDEP preventionseizure monitoringepilepsy wearableseizure alert devicecardiorespiratory monitoringmedical AIepilepsywearable sensorsSUDEP monitoringmedical deviceMedTechhealth IoTnighttime monitoringphysician portalFDA clearance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Neurava Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Neurava Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
SeedApr 3, 2024
SeedNov 1, 2021
GrantApr 9, 2021
Pre SeedDec 19, 2019

Key People

Founding team and executive leadership

Vivek Ganesh

Chief Technology Officer Co-Founder, Co-Founder

Founding Team

Neurava Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Apr 26, 2026

    Grew 60% QoQ from 5 to 8 employees.

Neurava Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Neurava Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Neurava's valuation, stock price, and market status.

Firmographic Details

HeadquartersIndianapolis, Indiana
Employee Range8
Year Founded2019
Last FundingApr 3, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.